PER percheron therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-2

  1. 3,966 Posts.
    lightbulb Created with Sketch. 917
    This is all we need to see...sound like most participants are continuing and no participant have withdrawn from the ...which is massive positive ...

    Rest is all the activities we all know about ..


    As at 30 September 2024, thirty four patients had completed participation in the blinded phase of the trial, comprising the first six months of treatment. Of these, three had
    completed all activities associated with trial participation, while the remainder
    continued in either the open-label phase of the study, comprising the second six months
    of treatment, or the four-month off-treatment follow-up period. To date, no patient has
    withdrawn from the trial prior to full completion.

    Glh...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $1.62K 180K

Buyers (Bids)

No. Vol. Price($)
4 364826 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 8026021 8
View Market Depth
Last trade - 10.37am 25/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.